GridAI Technologies (GRDX) Depreciation & Amortization (CF) (2015 - 2024)
GridAI Technologies' (GRDX) quarterly Depreciation & Amortization (CF) came in at $1336.0 in Q3 2024, down 81.7% YoY from $7300.0 in Q4 2023, and down 96.22% on a QoQ basis from $35317.0 in Q2 2024.
GridAI Technologies (GRDX) Depreciation & Amortization (CF) (2015 - 2024) Analysis & Trends
GridAI Technologies (GRDX) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $1336.0 in Q3 2024.
- Quarterly Depreciation & Amortization (CF) fell 81.7% year-over-year to $1336.0 in Q3 2024, while the trailing twelve-month figure through Jun 2025 was $1336.0 (down 97.85% YoY) and the FY2025 annual result came in at $574713.0, up 1074.18% from the prior year.
- Depreciation & Amortization (CF) eased to $1336.0 in Q3 2024, from $35317.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $35317.0 in Q2 2024 to a low of $1000.0 in Q1 2021.
- A 5-year average of $8420.3 and a median of $7300.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) sank 89.65% — and 2022, when it soared 630.0%.
- Tracing GRDX's Depreciation & Amortization (CF) over 5 years: stood at $11241.0 in 2020, then sank by 46.62% to $6000.0 in 2021, then rose by 16.67% to $7000.0 in 2022, then rose by 4.56% to $7319.0 in 2023, then tumbled by 81.75% to $1336.0 in 2024.
- The last three Depreciation & Amortization (CF) figures came in at $1336.0 (Q3 2024), $35317.0 (Q2 2024), and $12293.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1,336.00 |
| Sep 30, 2024 | 1,336.00 |
| Jun 30, 2024 | 35,317.00 |
| Jun 30, 2024 | 35,317.00 |
| Mar 31, 2024 | 12,293.00 |
| Mar 31, 2024 | 12,293.00 |
| Dec 31, 2023 | 7,319.00 |
| Dec 31, 2023 | 7,319.00 |
| Sep 30, 2023 | 7,300.00 |
| Sep 30, 2023 | 7,300.00 |
| Jun 30, 2023 | 7,300.00 |
| Jun 30, 2023 | 7,300.00 |
| Mar 31, 2023 | 7,318.00 |
| Mar 31, 2023 | 7,318.00 |
| Dec 31, 2022 | 7,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,300.00 |
| Sep 30, 2022 | 7,300.00 |
| Jun 30, 2022 | 7,300.00 |
| Jun 30, 2022 | 7,300.00 |